about
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Virological Mechanisms in the Coinfection between HIV and HCVThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyDiscovery of a synthetic dual inhibitor of HIV and HCV infection based on a tetrabutoxy-calix[4]arene scaffoldChanging Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in ChinaHepatitis C virus infection.Reinventing HCV Treatment: Past and Future Perspectives.Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy.Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicityMolecular mechanisms of liver fibrosis in HIV/HCV coinfectionInflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems.Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6.Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis.Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men.Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfectionSilibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaBHIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologiesInterleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problemsA humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.Effects of HCV on basal and tat-induced HIV LTR activationIncidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.Variation in both IL28B and KIR2DS3 genes influence pegylated interferon and ribavirin hepatitis C treatment outcome in HIV-1 co-infection.Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.HCV and HIV co-infection: mechanisms and management.HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitroLow levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action.HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosisRecent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors.Update on hepatitis C virus-specific immunityThe Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV CoinfectionChronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesisTrends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells.
P2860
Q26777511-97A40149-E110-4B85-9B8A-B3F3F9F83DEFQ26780313-FEBAEC26-B642-4325-9DFF-E50539CCB779Q26864344-A437D5BC-265D-4AEF-ACB0-1D4BC848D639Q27015778-E19DBF7F-0E8F-4F7F-A8C2-885B088F7712Q27491323-5FC3FEA5-665A-40A8-849D-31F4E88781B2Q28553922-A7311430-FF69-44F9-BD32-1DB6B68A81A8Q30235491-AF717C9A-FEF2-48A7-B4AA-E53529CEFBA7Q30241881-0452FC95-A46F-4E08-8D05-2218C8499479Q31054551-7B7D6334-6204-4F8E-8E10-F844612BBACCQ33638134-4282FAB6-586C-413B-B5B9-C87143B10CD4Q33705274-55F971FB-22D3-4258-AC00-CAE7464210C1Q33907429-2362DECE-522E-4510-B781-C033E7CCB66BQ33926735-1EE69F12-71C1-4115-9DC3-C8A1554700FAQ34063019-966469A4-83B5-4863-87C7-0F5961A970E2Q34199743-96D69ED3-CED9-4B56-8954-6726CDB882A3Q34250648-1FFB0ADC-3B65-4A0C-93B5-C702DF655BD3Q34295961-A85D7B13-4F46-4B5C-9F34-24FCD629E1C3Q34298877-F68F0E93-8F2A-469D-8048-60DBDE395F95Q34359120-683CF8CE-97D9-438C-AE80-2C65E5C2F301Q34509401-ADAC3A9F-57E3-46D4-B393-33E377852705Q34561257-86AEC333-3BCD-4D09-9FA0-A0C3B1892804Q34677793-91361723-A696-48CD-9D92-45EE30BA9927Q34733367-73240E67-F6C4-4ADA-BE2B-533B8292ACDCQ34769530-AA4DB360-7836-484A-905E-85E73FD1A7ABQ34777095-95715021-DD4B-4B0A-ADDF-315CDED29242Q34796111-AEF321FB-9E90-4A1F-B771-A5F40AC7F57CQ34852032-0296B6E6-7F93-42A0-8AC7-7D85BDE5E6F3Q35012716-9269D318-55F6-4ED1-8ED4-435F0A25810CQ35090634-496BAE40-9EB0-46ED-85A7-35247D695B50Q35105824-A0CFE268-9A56-416E-AECB-2D702E98747FQ35191924-8BF202B8-D9DC-4C57-8443-3348EE48BC2EQ35381792-5EB2D70A-199A-4C7F-BA94-E5F2C8393BF6Q35742761-59D3DC76-AABE-4DBC-9B66-22729C082534Q35766031-E5905CB3-4E38-4909-8FF0-888040779B7FQ35806970-35B90746-1FC5-4A78-9754-F8CBEC4F5B00Q35839496-A6A9A06F-138C-4458-9637-F5FD07A6455EQ35849638-608C9E42-5E74-417A-B913-ADBDC6BEF70EQ36019847-463D32C3-8840-4A00-A25E-4119E5A5E568Q36030846-0BE42061-8294-43FD-AA27-7AF73B1B41BFQ36065064-6FDC93A7-3AB8-42D1-8F5F-44C1AEC5993C
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Coinfection with HIV-1 and HCV--a one-two punch.
@ast
Coinfection with HIV-1 and HCV--a one-two punch.
@en
type
label
Coinfection with HIV-1 and HCV--a one-two punch.
@ast
Coinfection with HIV-1 and HCV--a one-two punch.
@en
prefLabel
Coinfection with HIV-1 and HCV--a one-two punch.
@ast
Coinfection with HIV-1 and HCV--a one-two punch.
@en
P2860
P1433
P1476
Coinfection with HIV-1 and HCV--a one-two punch.
@en
P2093
Arthur Y Kim
P2860
P304
P356
10.1053/J.GASTRO.2009.06.040
P407
P577
2009-06-21T00:00:00Z